DexCom Revenue 2010-2025 | DXCM
DexCom annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- DexCom revenue for the quarter ending March 31, 2025 was $1.036B, a 12.49% increase year-over-year.
- DexCom revenue for the twelve months ending March 31, 2025 was $4.148B, a 9.11% increase year-over-year.
- DexCom annual revenue for 2024 was $4.033B, a 11.34% increase from 2023.
- DexCom annual revenue for 2023 was $3.622B, a 24.49% increase from 2022.
- DexCom annual revenue for 2022 was $2.91B, a 18.84% increase from 2021.
| DexCom Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $4,033 |
| 2023 | $3,622 |
| 2022 | $2,910 |
| 2021 | $2,449 |
| 2020 | $1,927 |
| 2019 | $1,476 |
| 2018 | $1,032 |
| 2017 | $719 |
| 2016 | $573 |
| 2015 | $402 |
| 2014 | $259 |
| 2013 | $160 |
| 2012 | $100 |
| 2011 | $76 |
| 2010 | $49 |
| 2009 | $30 |
| DexCom Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1,036 |
| 2024-12-31 | $1,114 |
| 2024-09-30 | $994 |
| 2024-06-30 | $1,004 |
| 2024-03-31 | $921 |
| 2023-12-31 | $1,035 |
| 2023-09-30 | $975 |
| 2023-06-30 | $871 |
| 2023-03-31 | $742 |
| 2022-12-31 | $815 |
| 2022-09-30 | $770 |
| 2022-06-30 | $696 |
| 2022-03-31 | $629 |
| 2021-12-31 | $698 |
| 2021-09-30 | $650 |
| 2021-06-30 | $595 |
| 2021-03-31 | $505 |
| 2020-12-31 | $569 |
| 2020-09-30 | $501 |
| 2020-06-30 | $452 |
| 2020-03-31 | $405 |
| 2019-12-31 | $463 |
| 2019-09-30 | $396 |
| 2019-06-30 | $336 |
| 2019-03-31 | $281 |
| 2018-12-31 | $338 |
| 2018-09-30 | $267 |
| 2018-06-30 | $243 |
| 2018-03-31 | $184 |
| 2017-12-31 | $221 |
| 2017-09-30 | $185 |
| 2017-06-30 | $171 |
| 2017-03-31 | $142 |
| 2016-12-31 | $171 |
| 2016-09-30 | $149 |
| 2016-06-30 | $137 |
| 2016-03-31 | $116 |
| 2015-12-31 | $131 |
| 2015-09-30 | $105 |
| 2015-06-30 | $93 |
| 2015-03-31 | $73 |
| 2014-12-31 | $84 |
| 2014-09-30 | $69 |
| 2014-06-30 | $59 |
| 2014-03-31 | $47 |
| 2013-12-31 | $52 |
| 2013-09-30 | $43 |
| 2013-06-30 | $36 |
| 2013-03-31 | $30 |
| 2012-12-31 | $33 |
| 2012-09-30 | $23 |
| 2012-06-30 | $23 |
| 2012-03-31 | $20 |
| 2011-12-31 | $22 |
| 2011-09-30 | $18 |
| 2011-06-30 | $21 |
| 2011-03-31 | $14 |
| 2010-12-31 | $16 |
| 2010-09-30 | $12 |
| 2010-06-30 | $12 |
| 2010-03-31 | $10 |
| 2009-12-31 | $10 |
| 2009-09-30 | $7 |
| 2009-06-30 | $7 |
| 2009-03-31 | $5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $33.984B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $199.668B | 87.45 |
| Thermo Fisher Scientific (TMO) | United States | $151.715B | 18.35 |
| Edwards Lifesciences (EW) | United States | $45.473B | 29.82 |
| Alcon (ALC) | Switzerland | $43.302B | 29.26 |
| IDEXX Laboratories (IDXX) | United States | $42.214B | 48.51 |
| IQVIA Holdings (IQV) | United States | $26.351B | 14.76 |
| Mettler-Toledo (MTD) | United States | $24.614B | 29.27 |
| STERIS (STE) | Ireland | $23.975B | 26.41 |
| Waters (WAT) | United States | $20.898B | 29.49 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.583B | 0.00 |
| Hologic (HOLX) | United States | $14.336B | 15.58 |
| Sysmex ADR (SSMXY) | Japan | $10.191B | 28.91 |
| Penumbra (PEN) | United States | $10.026B | 78.69 |
| Masimo (MASI) | United States | $9.324B | 34.39 |
| Globus Medical (GMED) | United States | $8.112B | 19.33 |
| Teleflex (TFX) | United States | $5.426B | 8.96 |
| Glaukos (GKOS) | United States | $5.314B | 0.00 |
| TransMedics (TMDX) | United States | $4.703B | 102.24 |
| Integer Holdings (ITGR) | United States | $4.233B | 22.18 |
| PROCEPT BioRobotics (PRCT) | United States | $3.481B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.505B | 14.92 |
| Veracyte (VCYT) | United States | $2.151B | 30.18 |
| Nihon Kohden (NHNKY) | Japan | $2.052B | 23.53 |
| Elekta AB (EKTAY) | Sweden | $1.975B | 17.76 |
| Alphatec Holdings (ATEC) | United States | $1.861B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.384B | 0.00 |
| Artivion (AORT) | United States | $1.236B | 115.80 |
| Pulse Biosciences (PLSE) | United States | $1.150B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.054B | 5.60 |
| Beta Bionics (BBNX) | United States | $0.827B | 0.00 |
| SiBone (SIBN) | United States | $0.805B | 0.00 |
| IRadimed (IRMD) | United States | $0.769B | 39.03 |
| RxSight (RXST) | United States | $0.611B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.576B | 8.96 |
| Delcath Systems (DCTH) | United States | $0.570B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.567B | 13.30 |
| OrthoPediatrics (KIDS) | United States | $0.515B | 0.00 |
| AxoGen (AXGN) | United States | $0.497B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.449B | 0.00 |
| NeuroPace (NPCE) | United States | $0.431B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.430B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.390B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.368B | 9.79 |
| Treace Medical Concepts (TMCI) | United States | $0.365B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.342B | 0.00 |
| 908 Devices (MASS) | United States | $0.249B | 0.00 |
| Neuronetics (STIM) | United States | $0.245B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.233B | 14.14 |
| Sight Sciences (SGHT) | United States | $0.217B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.213B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.200B | 0.00 |
| Inogen (INGN) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.173B | 0.00 |
| CVRx (CVRX) | United States | $0.171B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.171B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.161B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.140B | 0.00 |
| Accuray (ARAY) | United States | $0.133B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.116B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.102B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.081B | 49.20 |
| InspireMD (NSPR) | United States | $0.077B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| Hyperfine (HYPR) | United States | $0.062B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.030B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.29 |